Cancer Gene Therapy · 2014 · 14 citations · 11 references
Life SciencesImmunologyOncologyCancer ImmunologyImmunotherapyTumor ImmunologyAntitumor T Cell ResponsesCancer ImmunotherapyCell-based ImmunotherapyCombination ImmunotherapyT Cell Responses To TumorsTumor-associated AntigensAntigen-specific T Cell ResponsesGene ElectrotransferMelanoma ImmunotherapyMetastasis SuppressionMurine ModelsPlasmid Dna VectorsRegulatory T Cell DepletionTumor Antigen-based Immunotherapy
Regulatory T cells (T-regs) can negatively impact tumor antigen-specific immune responses after infiltration into tumor tissue. However, depletion of T-regs can facilitate enhanced anti-tumor responses, thus augmenting the potential for immunotherapies. Here we focus on treating a highly aggressive form of cancer using a murine melanoma model with a poor prognosis. We utilize a combination of T-reg depletion and immunotherapy plasmid DNA delivered into the B16F10 melanoma tumor model via electroporation. Plasmids encoding murine granulocyte macrophage colony-stimulating factor and human B71 were transfected with electroporation into the tumor and transient elimination of T-regs was achieved with CD25-depleting antibodies (PC61). The combinational treatment effectively depleted T-regs compared to the untreated tumor and significantly reduced lung metastases. The combination treatment was not effective in increasing the survival, but only effective in suppression of metastases. These results indicate the potential for combining T-reg depletion with immunotherapy-based gene electrotransfer to decrease systemic metastasis and potentially enhance survival.
11
Loreé C. Heller, Carlos Pottinger, Mark J. Jaroszeski et al. · Melanoma Research · 2000 · 117 citations
Life Sciences, Immunology, Oncology +17
Melanoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Reinhard Dummer, Axel Hauschild, Merlin Guggenheim et al. · Annals of Oncology · 2010 · 105 citations · Full text
Medicine, Dermatology, Oncology +12